Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Treatment of hypercalcemia.

G T Elliott, M W McKenzie

    Drug Intelligence & Clinical Pharmacy
    |January 1, 1983
    PubMed
    Summary

    This study examined how doctors treat high blood calcium levels in patients. Researchers looked at records from 53 patients and found that a combination of several treatments is often used. These include giving patients fluids, using drugs to reduce calcium absorption, and helping the body get rid of excess calcium through urine. The study suggests that treatment is usually started when calcium levels reach a certain threshold. The findings may help doctors decide which treatments to use based on a patient’s specific situation.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Tyrosine kinase signaling in action potential shortening and expression of HSP72 in late preconditioning.

    American journal of physiology. Heart and circulatory physiology·2000
    Same author

    Preconditioning of swine heart with monophosphoryl lipid A improves myocardial preservation.

    The Annals of thoracic surgery·2000
    Same author

    The novel glycolipid RC-552 attenuates myocardial stunning and reduces infarct size in dogs.

    Journal of molecular and cellular cardiology·2000
    Same author

    Monophosphoryl lipid A: a novel nitric oxide-mediated therapy to attenuate platelet thrombosis?

    Journal of cardiovascular pharmacology·2000
    Same author

    Cellular mechanisms of infarct size reduction with ischemic preconditioning. Role of calcium?

    Annals of the New York Academy of Sciences·1999
    Same author

    Pharmacologic enhancement of tolerance to ischemic cardiac stress using monophosphoryl lipid A. A comparison with antecedent ischemia.

    Annals of the New York Academy of Sciences·1999

    Area of Science:

    • Endocrinology and metabolic disorders
    • Clinical pharmacology
    • Hospital medicine

    Background:

    Hypercalcemia remains a challenging clinical condition with limited consensus on optimal management strategies. Prior research has shown that elevated serum calcium levels can lead to significant morbidity if left untreated. Established knowledge includes the role of hydration in promoting renal excretion of calcium. However, this gap motivated further investigation into the comparative effectiveness of various treatment approaches. No prior work had resolved the best combination of therapies for different severity levels. Existing literature suggests that glucocorticosteroids may reduce calcium absorption in the gut. Yet, uncertainty remains about the most appropriate outpatient treatment protocols. This paper's contribution lies in analyzing real-world treatment patterns and outcomes in a clinical setting.

    Purpose Of The Study:

    The study aimed to evaluate treatment approaches for hypercalcemia using clinical data from patient records. Researchers focused on identifying which therapeutic strategies were most commonly employed. They sought to determine if specific combinations of treatments showed better outcomes. The motivation came from the lack of standardized protocols in managing hypercalcemia. By analyzing 72 admissions across 53 patients, they aimed to derive practical treatment principles. The study also aimed to assess when outpatient treatment is appropriate. Researchers wanted to clarify the role of forced diuresis in combination with other therapies. Their goal was to provide a decision-making framework for clinicians managing hypercalcemic patients.

    Keywords:
    Hypercalcemia managementClinical treatment protocolsSerum calcium levelsGlucocorticosteroid therapy

    Frequently Asked Questions

    The study suggests that combination therapy using glucocorticosteroids, oral phosphates, and forced diuresis is commonly used.

    Outpatient treatment is proposed when serum calcium levels are greater than or equal to 12 mg/dL.

    Forced diuresis is used to increase renal excretion of calcium and prevent fluid overload.

    Oral phosphates are proposed to bind calcium in the gastrointestinal tract and reduce absorption.

    Glucocorticosteroids are proposed to reduce intestinal calcium absorption and are commonly used in both inpatient and outpatient settings.

    Related Experiment Videos

    Main Methods:

    The study used a retrospective chart review of 72 admissions for hypercalcemia-related conditions. Researchers analyzed medical records from 53 patients to identify treatment patterns. They categorized interventions into hydration, forced diuresis, oral phosphates, and glucocorticosteroids. Data collection included serum calcium levels and treatment outcomes. The study focused on comparing inpatient versus outpatient treatment approaches. Researchers examined how often combination therapies were used in practice. They also assessed when treatment was initiated based on calcium levels. The analysis emphasized the frequency of using glucocorticosteroids alongside other interventions.

    Main Results:

    The most common treatment approach involved a combination of glucocorticosteroids, oral phosphates, and forced diuresis. Hydration was consistently used as a foundational treatment in inpatient settings. Outpatient management primarily relied on glucocorticosteroids and oral phosphates. Treatment was initiated when serum calcium reached or exceeded 12 mg/dL. Forced diuresis was frequently used in conjunction with other therapies. Oral phosphates were administered to bind calcium in the gastrointestinal tract. Glucocorticosteroids were used to reduce intestinal calcium absorption. The study found that combination therapy was preferred for more severe cases.

    Conclusions:

    The authors propose that combination therapy is a standard approach for managing hypercalcemia. They suggest that hydration and forced diuresis are essential in inpatient settings. The study indicates that outpatient treatment relies heavily on glucocorticosteroids. Researchers emphasize that treatment decisions should consider serum calcium levels. The findings suggest that oral phosphates play a supportive role in therapy. The study proposes that forced diuresis should be used cautiously to avoid dehydration. Authors suggest that treatment algorithms should guide clinical decisions. Their synthesis indicates that individualized treatment plans are necessary for optimal outcomes.

    The algorithm is proposed to guide clinicians in selecting the most efficacious treatment plan based on calcium levels and clinical context.